{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:25Z","timestamp":1786119505217,"version":"build-2736575974"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/hco.0b013e3283393c9b","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T02:25:17Z","timestamp":1271903117000},"page":"379-384","source":"Crossref","is-referenced-by-count":15,"title":["Aortic stenosis and lipids: does intervention work?"],"prefix":"10.1097","volume":"25","author":[{"given":"Anthony S","family":"Wierzbicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adie","family":"Viljoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1 Suppl","key":"R1-15-20210204","first-page":"61","article-title":"Aortic stenosis","volume":"38","author":"Ross","year":"1968","journal-title":"Circulation"},{"key":"R2-15-20210204","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-8703(80)90375-0","article-title":"The natural history of aortic stenosis in adults","volume":"99","author":"Chizner","year":"1980","journal-title":"Am Heart J"},{"key":"R3-15-20210204","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0002-9149(96)00235-4","article-title":"Natural history of aortic valve stenosis of varying severity in the elderly","volume":"78","author":"Iivanainen","year":"1996","journal-title":"Am J Cardiol"},{"issue":"Suppl E","key":"R4-15-20210204","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/9.suppl_E.57","article-title":"The natural history of aortic valve stenosis","volume":"9","author":"Horstkotte","year":"1988","journal-title":"Eur Heart J"},{"key":"R5-15-20210204","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF01711956","article-title":"Regression of valvular aortic stenosis due to homozygous familial hypercholesterolemia following plasmapheresis","volume":"64","author":"Keller","year":"1986","journal-title":"Klin Wochenschr"},{"key":"R6-15-20210204","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2004-822985","article-title":"Homozygous familial hypercholesterolemia and its management","volume":"4","author":"Marais","year":"2004","journal-title":"Semin Vasc Med"},{"key":"R7-15-20210204","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0735-1097(93)90249-Z","article-title":"Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample","volume":"21","author":"Lindroos","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"R8-15-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0002-9149(88)91375-6","article-title":"Frequency of angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis","volume":"62","author":"Vandeplas","year":"1988","journal-title":"Am J Cardiol"},{"key":"R9-15-20210204","first-page":"165","article-title":"Prevalence of atherosclerosis of the coronary and extracranial cerebral arteries in patients undergoing aortic valve replacement for calcified stenosis","volume":"15","author":"Kaden","year":"2006","journal-title":"J Heart Valve Dis"},{"key":"R10-15-20210204","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0002-9149(85)90149-3","article-title":"Case-control analysis of risk factors for presence of aortic stenosis in adults (age 50 years or older)","volume":"55","author":"Hoagland","year":"1985","journal-title":"Am J Cardiol"},{"key":"R11-15-20210204","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-9149(01)01821-5","article-title":"Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons","volume":"88","author":"Aronow","year":"2001","journal-title":"Am J Cardiol"},{"key":"R12-15-20210204","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0002-9149(87)91144-1","article-title":"Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients","volume":"59","author":"Aronow","year":"1987","journal-title":"Am J Cardiol"},{"key":"R13-15-20210204","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0002-9149(99)80263-X","article-title":"Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study)","volume":"76","author":"Gotoh","year":"1995","journal-title":"Am J Cardiol"},{"key":"R14-15-20210204","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.jacc.2005.12.073","article-title":"Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis","volume":"47","author":"Briand","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R15-15-20210204","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/db08-1515","article-title":"Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"58","author":"Katz","year":"2009","journal-title":"Diabetes"},{"key":"R16-15-20210204","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/oxfordjournals.eurheartj.a060602","article-title":"Factors associated with calcific aortic valve degeneration in the elderly","volume":"15","author":"Lindroos","year":"1994","journal-title":"Eur Heart J"},{"key":"R17-15-20210204","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R18-15-20210204","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2007.07.064","article-title":"Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study","volume":"50","author":"Novaro","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R19-15-20210204","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000213201","article-title":"Cardiac findings in the very elderly: analysis of echocardiography in fifty-eight nonagenarians","volume":"36","author":"Tunick","year":"1990","journal-title":"Gerontology"},{"key":"R20-15-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2310\/6650.2007.00010","article-title":"Epidemiology and genetics of calcific aortic valve disease","volume":"55","author":"O'Brien","year":"2007","journal-title":"J Investig Med"},{"key":"R21-15-20210204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ahj.2005.01.021","article-title":"Is it time to prescribe statins to patients with calcified aortic stenosis?","volume":"150","author":"Rashidi","year":"2005","journal-title":"Am Heart J"},{"key":"R22-15-20210204","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","article-title":"Characterization of the early lesion of \u2018degenerative\u2019 valvular aortic stenosis. Histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"key":"R23-15-20210204","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.ATV.16.4.523","article-title":"Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of \u2018degenerative\u2019 valvular aortic stenosis","volume":"16","author":"O'Brien","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R24-15-20210204","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.ATV.0000227513.13697.ac","article-title":"Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more)","volume":"26","author":"O'Brien","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R25-15-20210204","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.0000133194.94939.42","article-title":"Vascular calcification: mechanisms and clinical ramifications","volume":"24","author":"Abedin","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R26-15-20210204","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/hrt.2007.134783","article-title":"Aortic valve calcification: basic science to clinical practice","volume":"95","author":"Akat","year":"2009","journal-title":"Heart"},{"key":"R27-15-20210204","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.92.8.2163","article-title":"Osteopontin is expressed in human aortic valvular lesions","volume":"92","author":"O'Brien","year":"1995","journal-title":"Circulation"},{"key":"R28-15-20210204","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.athoracsur.2009.07.025","article-title":"Mechanical strain and the aortic valve: influence on fibroblasts, extracellular matrix, and potential stenosis","volume":"88","author":"Lehmann","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R29-15-20210204","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.106.682450","article-title":"Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study","volume":"115","author":"Ix","year":"2007","journal-title":"Circulation"},{"key":"R30-15-20210204","doi-asserted-by":"crossref","first-page":"H5","DOI":"10.1152\/ajpheart.00824.2009","article-title":"Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology","volume":"298","author":"Rajamannan","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R31-15-20210204","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/17434440.3.4.453","article-title":"Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology","volume":"3","author":"Skowasch","year":"2006","journal-title":"Expert Rev Med Devices"},{"key":"R32-15-20210204","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/187152608784746547","article-title":"Prediction of degeneration of native and bioprosthetic aortic valves: issue-related particularities of diabetes mellitus","volume":"8","author":"Yeghiazaryan","year":"2008","journal-title":"Infect Disord Drug Targets"},{"key":"R33-15-20210204","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0961203306071709","article-title":"Aortic valve calcification in systemic lupus erythematosus","volume":"15","author":"Kiani","year":"2006","journal-title":"Lupus"},{"key":"R34-15-20210204","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"R35-15-20210204","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and nonlipid effects of statins","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol Ther"},{"issue":"1 Suppl","key":"R36-15-20210204","first-page":"I566","article-title":"A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin","volume":"114","author":"Osman","year":"2006","journal-title":"Circulation"},{"key":"R37-15-20210204","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/14728222.12.10.1209","article-title":"Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment?","volume":"12","author":"Toli","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"R38-15-20210204","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jacc.2008.04.057","article-title":"In vivo aortic valve thermal heterogeneity in patients with nonrheumatic aortic valve stenosis the: first in vivo experience in humans","volume":"52","author":"Toutouzas","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R39-15-20210204","first-page":"411","article-title":"Pathogen burden in degenerative aortic valves is associated with inflammatory and immune reactions","volume":"18","author":"Skowasch","year":"2009","journal-title":"J Heart Valve Dis"},{"key":"R40-15-20210204","first-page":"560","article-title":"Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis","volume":"13","author":"Kaden","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"R41-15-20210204","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2003.09.015","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification","volume":"36","author":"Kaden","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"R42-15-20210204","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2796.2006.01624.x","article-title":"Molecular mechanisms of the vascular responses to haemodynamic forces","volume":"259","author":"Lehoux","year":"2006","journal-title":"J Intern Med"},{"key":"R43-15-20210204","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2796.2006.01621.x","article-title":"Endothelial mechanotransduction, nitric oxide and vascular inflammation","volume":"259","author":"Harrison","year":"2006","journal-title":"J Intern Med"},{"key":"R44-15-20210204","first-page":"62","article-title":"Mechanobiology of the aortic heart valve","volume":"17","author":"Butcher","year":"2008","journal-title":"J Heart Valve Dis"},{"key":"R45-15-20210204","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0149-2918(04)90031-8","article-title":"Association of dyslipidemia and effects of statins on nonmacrovascular diseases","volume":"26","author":"Baghdasarian","year":"2004","journal-title":"Clin Ther"},{"key":"R46-15-20210204","first-page":"416","article-title":"Aortic stenosis: an atherosclerotic disease?","volume":"8","author":"Wierzbicki","year":"1999","journal-title":"J Heart Valve Dis"},{"key":"R47-15-20210204","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijcard.2006.03.047","article-title":"Degeneration of native and tissue prosthetic valve in aortic position: do statins play an effective role in prevention?","volume":"116","author":"Colli","year":"2007","journal-title":"Int J Cardiol"},{"key":"R48-15-20210204","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.mol.0000137229.00020.fe","article-title":"Hyperlipidaemia and aortic valve disease","volume":"15","author":"Rossebo","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"R49-15-20210204","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1517\/14728222.12.7.809","article-title":"Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?","volume":"12","author":"Tziomalos","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"R50-15-20210204","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","article-title":"Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis","volume":"110","author":"Rosenhek","year":"2004","journal-title":"Circulation"},{"key":"R51-15-20210204","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"R52-15-20210204","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.amjcard.2008.04.060","article-title":"Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg)","volume":"102","author":"Dichtl","year":"2008","journal-title":"Am J Cardiol"},{"key":"R53-15-20210204","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","article-title":"Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis","volume":"49","author":"Moura","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R54-15-20210204","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"R55-15-20210204","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J Med"},{"key":"R56-15-20210204","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMsa0806603","article-title":"Analyses of cancer data from three ezetimibe trials","volume":"359","author":"Peto","year":"2008","journal-title":"N Engl J Med"},{"key":"R57-15-20210204","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1742-1241.2008.01888.x","article-title":"Muddy waters: more stormy SEAS for ezetimibe","volume":"62","author":"Wierzbicki","year":"2008","journal-title":"Int J Clin Pract"},{"key":"R58-15-20210204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacl.2008.11.002","article-title":"Not so choppy SEAS","volume":"3","author":"Williams","year":"2009","journal-title":"J Clin Lipidol"},{"key":"R59-15-20210204","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"R60-15-20210204","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Investigators","year":"2008","journal-title":"Lancet"},{"key":"R61-15-20210204","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.amjcard.2008.04.056","article-title":"Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis","volume":"102","author":"Antonini-Canterin","year":"2008","journal-title":"Am J Cardiol"},{"key":"R62-15-20210204","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1586\/14779072.6.3.385","article-title":"Aortic sclerosis, aortic stenosis and lipid-lowering therapy","volume":"6","author":"Rosenhek","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R63-15-20210204","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/07853890802331394","article-title":"Prevention of calcific aortic valve stenosis-fact or fiction?","volume":"41","author":"Cawley","year":"2009","journal-title":"Ann Med"},{"key":"R64-15-20210204","first-page":"381","article-title":"Development of aortic valve sclerosis or stenosis in rabbits: role of cholesterol and calcium","volume":"17","author":"Drolet","year":"2008","journal-title":"J Heart Valve Dis"},{"key":"R65-15-20210204","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1253\/circj.72.245","article-title":"Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis","volume":"72","author":"Linhartova","year":"2008","journal-title":"Circ J"},{"key":"R66-15-20210204","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.ATV.21.5.817","article-title":"Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R67-15-20210204","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.amjcard.2009.02.054","article-title":"Bone modifiers and the quest to slow progression of aortic stenosis","volume":"104","author":"Goldstein","year":"2009","journal-title":"Am J Cardiol"},{"key":"R68-15-20210204","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jacc.2009.01.064","article-title":"Hydroxymethylglutaryl coenzyme-a reductase inhibitors delay the progression of rheumatic aortic valve stenosis a long-term echocardiographic study","volume":"53","author":"Antonini-Canterin","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HCO.0b013e3283393c9b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:54Z","timestamp":1786040334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001573-201007000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e3283393c9b","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}